Cargando…

Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence

BACKGROUND: The beta-2-Adrenergic receptor (ADRB2) gene on chromosome 5q33.1 is an important immunoregulatory factor. We and others have previously implicated chromosomal region 5q31-33 for contribution to the genetic susceptibility to Graves disease (GD) in East-Asian populations. Two recent studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Xun, Dong, Yan, Shen, Min, Sun, Lingling, Dong, Changzheng, Wang, Yi, Wang, Beilan, Zhang, Kaiyue, Hua, Qi, Xu, Shijie, Huang, Wei
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666670/
https://www.ncbi.nlm.nih.gov/pubmed/19284637
http://dx.doi.org/10.1186/1471-2350-10-26
_version_ 1782166064780541952
author Chu, Xun
Dong, Yan
Shen, Min
Sun, Lingling
Dong, Changzheng
Wang, Yi
Wang, Beilan
Zhang, Kaiyue
Hua, Qi
Xu, Shijie
Huang, Wei
author_facet Chu, Xun
Dong, Yan
Shen, Min
Sun, Lingling
Dong, Changzheng
Wang, Yi
Wang, Beilan
Zhang, Kaiyue
Hua, Qi
Xu, Shijie
Huang, Wei
author_sort Chu, Xun
collection PubMed
description BACKGROUND: The beta-2-Adrenergic receptor (ADRB2) gene on chromosome 5q33.1 is an important immunoregulatory factor. We and others have previously implicated chromosomal region 5q31-33 for contribution to the genetic susceptibility to Graves disease (GD) in East-Asian populations. Two recent studies showed associations between the single nucleotide polymorphism (SNP) rs1042714 in the ADRB2 gene and GD. In this study, we aimed to fully investigate whether the ADRB2 gene conferred susceptibility to GD in Chinese population, and to perform a meta-analysis of association between ADRB2 and GD. METHODS: Approximately 1 kb upstream the transcription start site and the entire coding regions of the ADRB2 gene were resequenced in 48 Han Chinese individuals to determine the linkage disequilibrium (LD) patterns. Tag SNPs were selected and genotyped in a case-control collection of 1,118 South Han Chinese subjects, which included 428 GD patients and 690 control subjects. A meta-analysis was performed with the data obtained in the present samples and those available from prior studies. RESULTS: Fifteen SNPs in the ADRB2 gene were identified by resequencing and one SNP was novel. Ten tag SNPs were investigated further to assess association of ADRB2 in the case-control collection. Neither individual tag SNP nor haplotypes showed association with GD in Han Chinese population (P > 0.05). Our meta-analysis of the ADRB2 SNP rs1042714 measured heterogeneity between the ethnic groups (I(2 )= 53.1%) and no association to GD was observed in the overall three studies with a random effects model (OR = 1.13, 95% CI, 0.95 to 1.36; P = 0.18). However, significant association was found from the combined data of Caucasian population with a fixed effects model (OR = 1.18, 95% CI, 1.06 to 1.32; P = 0.002; I(2 )= 5.9%). CONCLUSION: Our study indicated that the ADRB2 gene did not exert a substantial influence on GD susceptibility in Han Chinese population, but contributed to a detectable GD risk in Caucasian population. This inconsistency resulted largely from between-ethnicity heterogeneity.
format Text
id pubmed-2666670
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26666702009-04-08 Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence Chu, Xun Dong, Yan Shen, Min Sun, Lingling Dong, Changzheng Wang, Yi Wang, Beilan Zhang, Kaiyue Hua, Qi Xu, Shijie Huang, Wei BMC Med Genet Research Article BACKGROUND: The beta-2-Adrenergic receptor (ADRB2) gene on chromosome 5q33.1 is an important immunoregulatory factor. We and others have previously implicated chromosomal region 5q31-33 for contribution to the genetic susceptibility to Graves disease (GD) in East-Asian populations. Two recent studies showed associations between the single nucleotide polymorphism (SNP) rs1042714 in the ADRB2 gene and GD. In this study, we aimed to fully investigate whether the ADRB2 gene conferred susceptibility to GD in Chinese population, and to perform a meta-analysis of association between ADRB2 and GD. METHODS: Approximately 1 kb upstream the transcription start site and the entire coding regions of the ADRB2 gene were resequenced in 48 Han Chinese individuals to determine the linkage disequilibrium (LD) patterns. Tag SNPs were selected and genotyped in a case-control collection of 1,118 South Han Chinese subjects, which included 428 GD patients and 690 control subjects. A meta-analysis was performed with the data obtained in the present samples and those available from prior studies. RESULTS: Fifteen SNPs in the ADRB2 gene were identified by resequencing and one SNP was novel. Ten tag SNPs were investigated further to assess association of ADRB2 in the case-control collection. Neither individual tag SNP nor haplotypes showed association with GD in Han Chinese population (P > 0.05). Our meta-analysis of the ADRB2 SNP rs1042714 measured heterogeneity between the ethnic groups (I(2 )= 53.1%) and no association to GD was observed in the overall three studies with a random effects model (OR = 1.13, 95% CI, 0.95 to 1.36; P = 0.18). However, significant association was found from the combined data of Caucasian population with a fixed effects model (OR = 1.18, 95% CI, 1.06 to 1.32; P = 0.002; I(2 )= 5.9%). CONCLUSION: Our study indicated that the ADRB2 gene did not exert a substantial influence on GD susceptibility in Han Chinese population, but contributed to a detectable GD risk in Caucasian population. This inconsistency resulted largely from between-ethnicity heterogeneity. BioMed Central 2009-03-13 /pmc/articles/PMC2666670/ /pubmed/19284637 http://dx.doi.org/10.1186/1471-2350-10-26 Text en Copyright © 2009 Chu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Chu, Xun
Dong, Yan
Shen, Min
Sun, Lingling
Dong, Changzheng
Wang, Yi
Wang, Beilan
Zhang, Kaiyue
Hua, Qi
Xu, Shijie
Huang, Wei
Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
title Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
title_full Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
title_fullStr Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
title_full_unstemmed Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
title_short Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
title_sort polymorphisms in the adrb2 gene and graves disease: a case-control study and a meta-analysis of available evidence
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666670/
https://www.ncbi.nlm.nih.gov/pubmed/19284637
http://dx.doi.org/10.1186/1471-2350-10-26
work_keys_str_mv AT chuxun polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT dongyan polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT shenmin polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT sunlingling polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT dongchangzheng polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT wangyi polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT wangbeilan polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT zhangkaiyue polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT huaqi polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT xushijie polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence
AT huangwei polymorphismsintheadrb2geneandgravesdiseaseacasecontrolstudyandametaanalysisofavailableevidence